New drug combo may boost stem cell success in sickle cell disease
NCT ID NCT05249452
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether giving sickle cell patients two drugs (azathioprine and hydroxyurea) for three months before a stem cell transplant could help the transplant work better. Twenty adults with a matched sibling donor took part. The goal was to see if this approach could reduce graft failure and allow patients to stop anti-rejection medication sooner.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SICKLE CELL DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Amsterdam Medical Centre
Amsterdam, Netherlands
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple screening test at birth save thousands of children with sickle cell disease?
- Can Eye-Tracking reveal hidden brain risks in babies with sickle cell disease?
- Can a peer coach help young people take control of their chronic illness?
- Could a stronger dose of an old drug protect children with sickle cell from organ damage?
- Gene editing could cure sickle cell by boosting fetal hemoglobin
- New stem cell processing method offers hope for patients without a perfect donor match